Surgical Tolls LLC (Senobox) develops products which improve clinical outcomes for patients selecting breast-conserving surgery (BCS) over mastectomy, despite the known increased risks associated with BCS, such as surgical re-excision and local recurrence of breast cancer. Specifically, Surgical Tools is developing products that enable three dimensional intra-operative radiographic margin assessment of excised breast tissue, as well as intraoperative microscopic margin assessment at the cellular level through spectroscopy. The company's objective is to reduce surgical re-excision and local recurrence rates in BCS by more than a factor of two in the next 3 years
